Clinical and biological characteristics | KIT L541 | KIT M541 | P b |
---|---|---|---|
N | 24 | 85 | |
Median size (mm) | 50 (17–240) | 60 (20–400) | |
Location | |||
Stomach | 12 (50 %) | 48 (56 %) | 0.6 |
Small bowel | 7 (29 %) | 28 (33 %) | 1 |
Mitotic index | |||
≤ 5 | 11 (50 %)a | 46 (54 %) | 0.8 |
6–10 | 2 (9 %)a | 15 (18 %) | 0.5 |
> 10 | 9 (41 %)a | 24 (28 %) | 0.4 |
Mutation status | |||
KIT Mutations | 15 (75 %)a | 49 (70 %)a | 0.8 |
KIT exon 11 | 10 (50 %)a | 42 (60 %)a | 0.5 |
KIT exon 9 | 3 (15 %)a | 5 (7 %)a | 0.4 |
KIT exon 13 | 2 (10 %)a | 0 | n/a |
KIT exon 17 | 0 | 2 (3 %)a | n/a |
PDGFRA Mutations | 2 (10 %)a | 9 (13 %)a | 1 |
PDGFRA exon 18 D842V | 1 | 8 | |
Wild Type | 3 (15 %)a | 12 (17 %)a | 1 |
Undetermined | 4 | 15 | |
Stage of the disease at diagnosis | |||
Localized | 15 (62 %) | 72 (85 %) | 0.02 |
Metastatic (or locally advanced/unresectable) | 9 (38 %) | 13 (15 %) |